Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Analyst Rating Guide

News

Back

Rani Therapeutics Hldgs Q1 EPS $(0.29) Beats $(0.31) Estimate

Author: Benzinga Newsdesk | May 06, 2024 04:27pm

Rani Therapeutics Hldgs (NASDAQ:RANI) reported quarterly losses of $(0.29) per share which beat the analyst consensus estimate of $(0.31) by 6.45 percent. This is a 12.12 percent increase over losses of $(0.33) per share from the same period last year.

Posted In: RANI